NASDAQ:MEDS

Wellgistics Health (MEDS) Stock Price, News & Analysis

Wellgistics Health logo
$0.73 -0.01 (-1.53%)
As of 04:00 PM Eastern

About Wellgistics Health Stock (NASDAQ:MEDS)

Advanced

Key Stats

Today's Range
$0.71
▼
$0.84
50-Day Range
$0.64
▼
$6.07
52-Week Range
$0.49
▼
$33.13
Volume
19.06 million shs
Average Volume
863,001 shs
Market Capitalization
$2.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Wellgistics Health is a U.S.-focused healthcare services and technology company centered on pharmaceutical distribution. It supplies prescription medicines, including branded and generic drugs, to pharmacies and other healthcare providers.

The company also offers technology and services intended to support pharmacy purchasing, inventory management and connections among drug manufacturers, distributors and pharmacies. Its business is particularly oriented toward serving independent pharmacies.

Wellgistics Health combines pharmaceutical wholesale distribution with technology-enabled pharmacy services. The company’s operations are focused on the U.S. healthcare market.

AI Generated. May Contain Errors.

Wellgistics Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

MEDS MarketRank™: 
0.77364680153 of 5 stars

Wellgistics Health scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Wellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Wellgistics Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Wellgistics Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Wellgistics Health is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Wellgistics Health is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Wellgistics Health has a P/B Ratio of 14.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    15.91% of the float of Wellgistics Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Wellgistics Health has a short interest ratio ("days to cover") of 0.52, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Wellgistics Health has recently decreased by 22.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Wellgistics Health does not currently pay a dividend.

  • Dividend Growth

    Wellgistics Health does not have a long track record of dividend growth.

  • News Sentiment

    Wellgistics Health has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Wellgistics Health this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added Wellgistics Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Wellgistics Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.45% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    5.68% of the stock of Wellgistics Health is held by institutions.

  • Read more about Wellgistics Health's insider trading history.
Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Wellgistics Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MEDS Stock News Headlines

Wellgistics Health (MEDS) versus Its Competitors Critical Survey
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
See More Headlines

MEDS Stock Analysis - Frequently Asked Questions

Wellgistics Health's stock was trading at $20.00 on January 1st, 2026. Since then, MEDS stock has decreased by 96.4% and is now trading at $0.7277.

Wellgistics Health, Inc. (NASDAQ:MEDS) posted its quarterly earnings data on Monday, August, 17th. The company reported ($7.13) earnings per share for the quarter. The firm had revenue of $1.78 million for the quarter.

Wellgistics Health's stock reverse split on Tuesday, May 26th 2026.The 1-50 reverse split was announced on Wednesday, May 20th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/17/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NASDAQ:MEDS
Previous Symbol
NASDAQ:WGRX
CIK
2030763
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($20.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$101.28 million
Net Margins
-564.70%
Pretax Margin
-565.42%
Return on Equity
N/A
Return on Assets
-105.00%

Debt

Debt-to-Equity Ratio
8.53
Current Ratio
0.14
Quick Ratio
0.10

Sales & Book Value

Annual Sales
$23.34 million
Price / Sales
0.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.05 per share
Price / Book
14.55

Miscellaneous

Outstanding Shares
3,200,000
Free Float
2,576,000
Market Cap
$2.33 million
Optionable
N/A
Beta
-3.14
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:MEDS) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners